181 related articles for article (PubMed ID: 22219167)
1. Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO.
Kojima T; Higashi K; Suzuki T; Tomono K; Moribe K; Yamamoto K
Pharm Res; 2012 Oct; 29(10):2777-91. PubMed ID: 22219167
[TBL] [Abstract][Full Text] [Related]
2. Insights into atomic-level interaction between mefenamic acid and eudragit EPO in a supersaturated solution by high-resolution magic-angle spinning NMR spectroscopy.
Higashi K; Yamamoto K; Pandey MK; Mroue KH; Moribe K; Yamamoto K; Ramamoorthy A
Mol Pharm; 2014 Jan; 11(1):351-7. PubMed ID: 24283196
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insight into the dramatic improvement of probucol dissolution in neutral solutions by solid dispersion in Eudragit E PO with saccharin.
Higashi K; Seo A; Egami K; Otsuka N; Limwikrant W; Yamamoto K; Moribe K
J Pharm Pharmacol; 2016 May; 68(5):655-64. PubMed ID: 26272472
[TBL] [Abstract][Full Text] [Related]
4. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
Kang N; Lee J; Choi JN; Mao C; Lee EH
Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability.
Ochi M; Kimura K; Kanda A; Kawachi T; Matsuda A; Yuminoki K; Hashimoto N
AAPS PharmSciTech; 2016 Aug; 17(4):932-9. PubMed ID: 27435198
[TBL] [Abstract][Full Text] [Related]
6. Methacrylate-Copolymer Eudragit EPO as a Solubility-Enabling Excipient for Anionic Drugs: Investigation of Drug Solubility, Intestinal Permeability, and Their Interplay.
Fine-Shamir N; Dahan A
Mol Pharm; 2019 Jul; 16(7):2884-2891. PubMed ID: 31120762
[TBL] [Abstract][Full Text] [Related]
7. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
Owusu-Ababio G; Ebube NK; Reams R; Habib M
Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of dissolution and absorption of mefenamic acid by egg albumin.
Imai T; Nohdomi K; Acartürk F; Otagiri M
J Pharm Sci; 1991 May; 80(5):484-7. PubMed ID: 1880730
[TBL] [Abstract][Full Text] [Related]
9. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
10. The effect of some acrylic polymers on dissolution of celecoxib solid dispersion formulations.
Maghsoodi M; Nokhodchi A; Pourasghari Azar H
Pharm Dev Technol; 2021 Sep; 26(7):788-796. PubMed ID: 34159879
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Study of Molecular Interactions of Anionic Drugs with a Dimethylaminoethyl Methacrylate Copolymer Regarding Solubility Enhancement.
Saal W; Ross A; Wyttenbach N; Alsenz J; Kuentz M
Mol Pharm; 2017 Apr; 14(4):1243-1250. PubMed ID: 28287743
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations.
Abu-Diak OA; Jones DS; Andrews GP
Mol Pharm; 2011 Aug; 8(4):1362-71. PubMed ID: 21696180
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-Eudragit® E PO solid dispersion: A simple and potent method to solve the problems of curcumin.
Li J; Lee IW; Shin GH; Chen X; Park HJ
Eur J Pharm Biopharm; 2015 Aug; 94():322-32. PubMed ID: 26073546
[TBL] [Abstract][Full Text] [Related]
15. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment.
Kerdsakundee N; Mahattanadul S; Wiwattanapatapee R
Eur J Pharm Biopharm; 2015 Aug; 94():513-20. PubMed ID: 26143367
[TBL] [Abstract][Full Text] [Related]
18. Coloration phenomenon of mefenamic acid in mesoporous silica FSM-16.
Moribe K; Kinoshita R; Higashi K; Tozuka Y; Yamamoto K
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):214-8. PubMed ID: 20118582
[TBL] [Abstract][Full Text] [Related]
19. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer?
Lee EH; Byrn SR
J Pharm Sci; 2010 Sep; 99(9):4013-22. PubMed ID: 20589947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
